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Background: Fatigue is an important problem in paediatric cancer patients and yoga may be an effective
intervention. The primary objective was to determine the feasibility of individualized yoga for hospitalized children
receiving intensive chemotherapy.
Methods: We included English-speaking children and adolescents aged 7–18 years receiving intensive chemotherapy
or haematopoietic stem cell transplantation (HSCT). Yoga was conducted three times weekly for three weeks. The
primary outcome was feasibility, defined as ability to deliver at least 60% of planned sessions. Secondary outcomes
were parent-reported Pediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale, Fatigue Scale-Parent,
PedsQL Generic Core Scales and PedsQL Acute Cancer Module.
Results: Between January and October 2013, 11 patients were enrolled. Median age was 14.0 (range 7.7-16.4) years
and 6 (55%) were boys. Yoga was feasible with 10/11 participants meeting the threshold for feasibility. The median
number of yoga sessions was 9 (range 3–13). No adverse events were attributed to yoga. Mean ± standard deviation
for the day 21 proxy-reported PedsQL general fatigue scores was 55.6 ± 15.5. Qualitative comments suggested design
changes for future yoga studies.
Conclusions: Individualized yoga is feasible for inpatient children receiving intensive chemotherapy. Future work will
include development and conduct of a randomized trial for fatigue amelioration.
Trial registration: ClinicalTrials.gov NCT02105389.
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Cancer-related fatigue can be described as a subjective
feeling of physical, emotional, and/or cognitive tiredness
[1]. It is thought to be commonly under-recognized, not
reported and poorly managed [2]. Further, it is prevalent
in children with cancer [3-5]. Three cross-sectional stud-
ies conducted in children 10 to 18 years of age found
that lack of energy was the most common symptom, oc-
curring in 50% to 76% of participants [4,6,7]; fatigue* Correspondence: lillian.sung@sickkids.ca
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unless otherwise stated.symptoms were moderate to very severe in intensity.
Fatigue is frequently identified as the most trouble-
some symptom in paediatric cancer patients with an
important impact on quality of life (QoL) [8]. Inpatient
status and recent chemotherapy are significant predictors
of worse fatigue in children [7,9]. Based on severity of
illness, anaemia, concurrent medications, inactivity and
prolonged inpatient status, children with cancer receiving
intensive chemotherapies are expected to be at high risk
for severe fatigue.
Guidelines suggest that all cancer patients, including
children as young as 5 years of age, should be routinely
screened for fatigue [10]. These guidelines also suggest
fatigue should be managed according to clinical practice
standards. However, evidence demonstrating effectiveThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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scarce. In a recent systematic review of 72 random-
ized controlled trials (RCTs) which included participants
of all ages, exercise reduced fatigue by a moderate amount
with a standardized mean difference of −0.45, 95% confi-
dence interval (CI) -0.57 to −0.32 (P < 0.001). Type of ex-
ercise (aerobic, walking, resistance, yoga or mixed) did not
impact on exercise efficacy (P for interaction = 0.35) [11].
Unfortunately, only one study was paediatric-specific.
We hypothesized that yoga would be an ideal interven-
tion for children receiving the most intensive chemo-
therapy as these children may be too ill to participate in
other types of exercise programs. Yoga is a unique inter-
vention that combines exercise and mindfulness. Inten-
sity of the yoga practice can be titrated to a patient’s
current status and yoga can be delivered in any location
without the need for specialized equipment.
In order to evaluate the efficacy of individualized yoga, a
RCT is required. However, prior to proceeding to a defini-
tive randomized trial, conduct of a pilot study is important
to ensure that a RCT is feasible, to facilitate design of the
RCT and to estimate variability of the outcome measure
[12]. The primary objective was to determine the feasibil-
ity of individualized yoga for hospitalized children receiv-
ing intensive chemotherapy. Secondary objectives were to
describe: (1) Parent/guardian proxy-report child fatigue
scores; (2) Proxy-report child QoL; (3) Self-report parent
QoL; (4) Number of children willing to self-report symp-
toms; and (5) Qualitative suggestions to improve trial
conduct.
Methods
This was a pilot trial of individualized yoga for fatigue in
children 7 to 18 years of age receiving intensive chemother-
apy at The Hospital for Sick Children (SickKids), Toronto.
This study received Research Ethics Board approval from
SickKids and all participants/guardians provided informed
consent and assent as appropriate.
Subjects
We included children and adolescents who were: (1)
Diagnosed with any acute myeloid leukemia (AML),
relapsed acute lymphoblastic leukemia, stage 3 or 4
Burkitt’s lymphoma/leukemia or about to receive au-
tologous or allogeneic haematopoietic stem cell trans-
plantation (HSCT); (2) Expected to be an inpatient for
at least three weeks after initiation of chemotherapy or
conditioning; and (3) Ages 7 to 18 years at enrollment.
Exclusion criteria were as follows: (1) Features present
to an extent that would preclude compliance with yoga
(as assessed by the attending physician): a) motor disabil-
ity, b) cognitive disability, c) cardiopulmonary symptoms,
or d) known compression fracture resulting in disability;
and (2) Parent or patient cannot understand English.Site
All subjects were recruited from a single site, SickKids
in Toronto, Canada. SickKids is the tertiary care referral
center for the Greater Toronto area and is the only cen-
ter that performs paediatric HSCT in the province of
Ontario.
Study procedures
All participants received yoga; yoga began between day −1
to day +4 after starting any course of chemotherapy or
conditioning regimens for HSCT. Treatment was adminis-
tered by one of three trained children’s yoga instructors.
All yoga instructors were certified teachers in children’s
yoga and also received study-specific yoga training. It was
intended for yoga to occur three times weekly for 3 weeks.
However, mid-way through the pilot study, we appreciated
that it was difficult to identify 3 appropriate days for yoga
in advance because of acuity of illness, scheduling of tests
such as computerized tomography scans and other radio-
logical evaluations, and procedures. Consequently, we began
to offer yoga daily excluding weekends and holidays
(in other words, 4 to 5 times weekly) with the goal of
achieving sessions three times weekly.
There was a common structure for all sessions that
started with relaxation and breathing followed by a series
of poses focused on strengthening, flexibility, and bal-
ance. Each session terminated with a period of relaxation
(savasana). Yoga instructors were asked to select appro-
priate poses from a pre-determined list of poses for each
session. There were low, moderate and high intensity regi-
mens available depending on the wishes and abilities of
the child and parent and the judgment of the yoga in-
structor. The target intensity was documented and could
change with each yoga session. Children were encouraged
to choose a focus for each session such as working on a
new pose they learned in a previous session, practicing
balancing, focusing on deep breathing or focusing on
clearing their mind. For each session, the parent or an-
other family member was offered the opportunity to per-
form yoga along with the child and instructor.
Outcomes
The primary outcome was feasibility, defined as the abil-
ity to deliver at least 60% of the planned three times
weekly yoga sessions in at least 70% of participants. The
time frame evaluated began at the first session and ex-
tended until day 21, discharge date or date off study,
whichever occurred first. For secondary outcomes, par-
ent proxy-reported child fatigue and QoL were of main
interest. We also included child self-reported fatigue and
QoL as well as parent self-reported QoL to identify the
feasibility and utility of these measures. Parents were the
primary respondents while children were encouraged to
self-report if they wished. All instruments used a 7 day
Table 1 Demographics of the study cohort
Characteristic Value N = 11
Male (%) 6 (54.6)
Median age in years (range) 14.0 (7.7-16.4)
Diagnosis (%)
Leukemia/lymphoma 8 (72.7)
Solid tumor 1 (9.1)
Brain tumor 1 (9.1)
Aplastic anemia 1 (9.1)
Median months since diagnosis (IQR) 2.2 (0.2, 8.6)
Relapse status (%) 1 (9.1)
Current treatment
Chemotherapy (%) 5 (45.4)
Stem cell transplantation (%) 6 (54.6)
Parent/other participated in at least one session (%) 9 (81.8)
Child previous experience with yoga 3 (27.3)
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days 7, 14 and 21 except the Short Form-36 (SF-36)
which was administered at baseline and on day 21.
In order to measure fatigue, we included the two instru-
ments with sufficient psychometric evaluation to permit
inclusion in trials [13], namely the Pediatric Quality of
Life Inventory (PedsQL) Multidimensional Fatigue Scale
(MFS) [14] and the Fatigue Scale-Child, Adolescent and
Parent (FS-C, FS-A and FS-P) [15]. The PedsQL MFS is
an 18-item instrument that assesses general fatigue, sleep/
rest fatigue and cognitive fatigue; it is reliable and valid in
children with cancer [14]. We were most interested in
general and sleep/rest fatigue. The FS-P is proxy-report
and the FS-C (10-items) and FS-A (13-items) are child
and adolescent self-report. All scales are reliable, valid and
sensitive to change when used longitudinally [16,17].
To measure child QoL, we used the PedsQL 4.0 Generic
Core Scale and PedsQL 3.0 Acute Cancer Module. The
PedsQL is a multidimensional instrument that is reliable
and valid in healthy populations and in children with can-
cer [14,18-21]. From the generic scale, we were most in-
terested in the physical and psychosocial summary scores.
From the cancer module, we were most interested in pain
and hurt, nausea, anxiety and worry.
In order to measure parent QoL, the Short Form (SF)-
36 was used. The SF-36 is composed of 36 items that
measure physical function, role physical function, bodily
pain, general health perception, mental health, role emo-
tional function, energy, and social function [22,23]. Scores
for each domain range from 0 to 100, with higher scores
indicating better QoL. It results in a physical and a mental
health component summary score which have a mean of
50 and standard deviation of 10, representing the mean
and standard deviation of the general United States popu-
lation. The SF-36 is valid and internally consistent [22,23].
In addition to these quantitative measures, qualitative
comments were collected at each assessment time point
throughout the study. Participants were asked what they
liked and disliked about the yoga program and whether
or not they felt the yoga program was of benefit.
Statistical analysis
Feasibility was defined as the ability to deliver at least
60% of the planned three times weekly yoga sessions
over the evaluation time frame in at least 70% of partici-
pants. We had planned to enroll a minimum of 10 and a
maximum of 20 patients to allow modifying the program
in the event significant barriers were identified.
Results and discussion
Between January and October 2013, we assessed 22 potential
patients. Of those screened, 5 refused, 6 were missed (not
identified during the period of eligibility) and 11 consented
to participate. Demographic characteristics are illustrated inTable 1. Median age was 14.0 (range 7.7-16.4) years and 6
(55%) were boys. Six children had AML (3 with acute pro-
myelocytic leukemia) and 6 (55%) were undergoing HSCT.
Two children who participated had co-morbidities. One
child had ataxia and a compression fracture (not resulting in
disability) and one child had cellulitis.
We found that yoga was feasible with 10/11 partici-
pants meeting the a priori defined threshold. The me-
dian number of yoga sessions was 9 (range 3 to 13).
Only one 7 year old child stopped yoga after three ses-
sions because it was not “fast paced” enough for her.
No adverse events were experienced, and specifically
no musculoskeletal, bleeding or central line issues were
attributed to yoga. When the total number of sessions
was considered, 26% were associated with family-
member participation. Of the 11 participants, 8 had a
family member participate in at least one session. The
median age of children who had at least one session
with a family member co-participating was 13.5 (range
7 to 16) years. The ages of the child participants with-
out any family member participation were 13, 14 and
16 years.
The proxy-report fatigue scores according to the PedsQL
MFS and FS-P are illustrated in Table 2. Proxy-report gen-
eric and cancer-specific QoL are also illustrated in Table 2.
Only 3 children self-reported fatigue and QoL scores and
thus, these scores are not presented. Parent/guardian
self-reported QoL according to the SF-36 is illustrated
in Table 3.
Qualitative feedback from both children and parents
indicated physical and psychological benefits of yoga.
Both children and parents noted physical impacts such
as increased energy levels, decreased nausea and a
Table 2 Proxy report fatigue and quality of life scores*
Day 0 Day 7 Day 14 Day 21
N Median (IQR) N Median (IQR) N Median (IQR) N Median (IQR)
Fatigue
PedsQL Multi-dimensional Fatigue Scale
General fatigue 11 50.0 (20.8, 70.8) 10 56.3 (35, 62.5) 9 50.0 (33.3, 70.8) 9 50.0 (45.8, 70.8)
Sleep/Rest Fatigue 11 62.5 (20.8, 66.7) 10 41.7 (29.2, 54.2) 9 33.3 (29.2, 41.7) 9 54.2 (37.5, 66.7)
Fatigue Scale - Parent 10 40.0 (34.0, 44.0) 10 46.5 (44.0, 52.0) 10 45.5 (39.0, 49.0) 9 44.0 (43.0, 48.0)
Quality of Life
PedsQL Cancer Module
Pain and hurt 11 50.0 (37.5, 75.0) 10 62.5 (25.0, 87.5) 7 50.0 (25.0, 75.0) 9 75.0 (37.5, 75.0)
Nausea 11 50.0 (35.0, 75.0) 9 50.0 (35.0, 55.0) 7 60.0 (35.0, 80.0) 9 50.0 (40.0, 75.0)
Procedural Anxiety 11 50.0 (25.0, 91.7) 9 58.3 (25.0, 100) 6 95.8 (50.0, 100) 9 66.7 (41.7, 100)
Treatment Anxiety 11 75.0 (50.0, 100) 9 66.7 (50.0, 100) 6 87.5 (50.0, 100) 9 75.0 (75.0, 100)
Worry 11 58.3 (41.7, 83.3) 10 62.5 (50.0, 83.3) 7 75.0 (50.0, 83.3) 9 75.0 (50.0, 83.3)
PedsQL Generic Core
Physical health 11 64.3 (40.6, 71.9) 10 48.4 (12.5, 68.8) 8 59.1 (34.4, 73.4) 6 59.9 (25.0, 75.0)
Psychosocial health 11 68.8 (60.0, 81.7) 10 62.8 (56.7, 70.5) 8 73.8 (65.3, 79.6) 9 70.0 (65.0, 80.0)
Abbreviation: IQR = interquartile range *Where N < 11, evaluations were missing.
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fits included reduced anxiety and agitation, better sleep
and improved mood. Many children felt yoga had given
them the opportunity to relax and ‘escape’ from the hectic
hospital environment.
Several comments will lead to design changes as fol-
lows. First, parents felt that four assessments were overly
burdensome and that there were too many question-
naires with each assessment. Second, parents noted the
social and school functioning questions of the PedsQL
Generic Core Scales were not relevant given the inpatientTable 3 Parent quality of life scores*
Day 0 Day 21
N Median (IQR) N Median (IQR)
Physical Health Summary 9 47.7 (45.0, 62.6) 7 52.2 (41.5, 61.0)
Physical functioning 11 46.5 (40.2, 57.0) 8 52.8 (42.3, 57.0)
Role-physical 10 47.1 (37.3, 56.9) 7 54.4 (32.4, 56.9)
Bodily pain 10 53.3 (41.4, 62.1) 8 58.8 (41.4, 62.1)
General health 10 45.8 (38.6, 57.7) 8 56.5 (45.8, 62.0)
Mental Health Summary 9 38.4 (33.8, 45.9) 7 48.1 (29.5, 56.7)
Vitality 11 49.0 (33.4, 58.3) 8 44.3 (38.1, 59.9)
Social functioning 11 45.9 (24.1, 51.4) 8 48.7 (35.0, 56.8)
Role-emotional 10 42.3 (36.4, 55.9) 8 44.3 (26.8, 55.9)
Mental health 10 44.4 (33.1, 50.0) 8 50.0 (38.7, 54.2)
Abbreviation: IQR = interquartile range *Where N < 11, evaluations
were missing.status of their children. Finally, we found that three times
weekly yoga was not an optimal schedule since children
may not be available for yoga on a given day related to ill-
ness or medical procedures/diagnostic tests. We asked the
last 3 children enrolled whether they would participate in
a future RCT of yoga if given the opportunity; all 3 said
they would participate.
We found that individualized yoga in children receiving
intensive chemotherapy is feasible. Our patient population
primarily consisted of children with AML and those
undergoing HSCT. These children are expected to be-
come profoundly neutropaenic with multiple toxicities of
therapy including fever, invasive infection and mucositis
and a relatively high treatment-related mortality rate.
Consequently, the ability to conduct yoga in this inten-
sively treated and often acutely ill population is very en-
couraging. We also found that it is feasible to measure
fatigue and QoL in these children provided parents are
the primary respondents.
In addition, our study provided insight into ways to
improve the design of a future RCT. Because of the bur-
densome nature of outcome assessments, we will reduce
the number of assessments to three: baseline, day 10 and
day 21. We plan to eliminate the PedsQL Generic Core
Scales because of lack of relevance and the SF-36 since
caregiver health is not of primary interest, in order to
decrease the burden of questionnaire administration.
Finally, to improve the ability to deliver yoga, we will
change the intervention schedule to daily excluding
weekends. Our data also support proxy-response as the
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to self-report symptoms.
Our results are concordant with three other yoga
feasibility studies. First, Thygeson and colleagues [24]
explored the feasibility of a single yoga session for chil-
dren 7 to 18 years hospitalized with cancer or other
blood disorders. A yoga class was held in the inpatient
unit playroom and administered by a researcher who
was also a registered yoga teacher. Eleven children par-
ticipated; the session was feasible and received positive
feedback. A second feasibility study of 5 weekly yoga
sessions was conducted in 6 children with a variety of
cancer types [25]. In this study, a low-impact program
was developed by the authors that incorporated ele-
ments such as stretching, strengthening and relaxation.
The yoga sessions were one hour long, conducted in a
group setting, were uniquely adapted to individual pa-
tients and were facilitated by physical and occupational
therapists, assistants and rehabilitation aides [25]. One
child with AML (5 years of age) and two children post
HSCT (12 and 19 years of age) were included. The inter-
vention was feasible; children found that they looked
forward to participating in the yoga sessions and that
the sessions always made them feel better afterwards
[25]. A third study demonstrated the feasibility of a
12 week community based program for out-patient chil-
dren with any type of cancer. Sessions were conducted
twice weekly and the authors reported preliminary evi-
dence of program benefits on QoL [26]. Our study is
unique, however, as it applies individualized yoga up to
5 times weekly among an intensively treated cancer
and HSCT inpatient paediatric population and evalu-
ated the feasibility of measuring specified fatigue and
QoL outcomes.
Because of the single armed nature of this pilot study,
it is not possible to estimate the effect of yoga on fatigue
and QoL outcomes and thus, the definitive RCT will be
important to clarify the utility of yoga in this setting.
The ability to translate the intervention to a multi-
center trial will rely upon careful description of the yoga
intervention and training. In our feasibility study, we de-
veloped and followed a detailed yoga program and plan
to disseminate this information in a subsequent publica-
tion. For the future RCT, we plan to provide in-person
training to site yoga instructors and to monitor 20% of
yoga sessions remotely to ensure fidelity to the program
and safety of the intervention. The future RCT will need
to consider the minimally clinically important difference
in the fatigue outcome in order to appropriately power
the study.
The strengths of this study are the a priori designated
definition of feasibility and identification of several key
ways to improve the design of the future RCT. However,
there are limitations of our study. The most importantlimitation is that we did not perform randomization
within this pilot study and thus, we did not demonstrate
the feasibility of enrolling children to a randomized trial.
However, all 3 participants who were asked, stated that
they would participate in a future RCT of yoga if invited,
which provides some reassurance. Second, we performed
this pilot study at a single site to ensure we had max-
imum control of the sessions and outcome ascertain-
ment while we were still in the development phase of
the yoga program. A third limitation was the defined
threshold for feasibility, namely completion of at least
60% of the planned three times weekly sessions. This
threshold was chosen based on balancing what was likely
to be achievable in such an intensively treated popula-
tion at risk for life-threatening complications and the
number of sessions expected to be required to achieve
benefit. However, we recognize that this threshold is
lower than standards in the exercise field. Another limi-
tation is that we did not define other elements of feasi-
bility, such as duration of sessions, intensity of sessions
and completion of required poses. Further research should
focus on such elements.
Conclusions
In summary, individualized yoga is feasible for children
with cancer receiving intensive chemotherapy and under-
going HSCT. Future work will proceed toward develop-
ment and conduct of a RCT of individualized yoga to
reduce fatigue in children with cancer and HSCT. Identifi-
cation of an effective intervention is an important step
toward reducing fatigue and improving QoL in this patient
population.
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